Favorable treatment outcomes in patients with SMA diagnosed through newborn screening

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Oct 12 / Springer Healthcare

Favorable treatment outcomes in patients with SMA diagnosed through newborn screening

Neuroscience Spinal Muscular Atrophy WMS-2022

Description

Peter Karachunski reports the findings from a real-world study showing that disease-modifying therapies have favorable safety and effectiveness profiles in infants with spinal muscular atrophy identified through newborn screening.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.